Specialty Pharma Journal Specialty, Precision & Technology
Researchers at Yale Cancer Center have identified a new subtype of triple negative breast cancer that shows significantly improved response to chemotherapy. Patients with the newly defined subtype — BRCA-deficient triple negative breast cancer — had significantly higher survival rates with chemotherapy. The study was published on Dec. 13 in …
Tag Archives: yale
December, 2016
January, 2015
-
15 January
Johnson & Johnson Becomes First Devicemaker to Share Clinical Trial Data
Health care giant Johnson & Johnson (J&J) is the first device-maker to agree to broadly share clinical trial data for its medical devices and diagnostics with a medical school. J&J struck a deal with the Yale University Open Data Access (YODA) Project to make results from its clinical trials of …